Nearly complete hair re-pigmentation in an older patient treated with hydroxyurea for essential thrombocytosis.

IF 1 4区 医学 Q4 ONCOLOGY
Shiva Salmasi, Ruba Alchaikh Hassan, Zahra Gafarzadeh, Constantin A Dasanu
{"title":"Nearly complete hair re-pigmentation in an older patient treated with hydroxyurea for essential thrombocytosis.","authors":"Shiva Salmasi, Ruba Alchaikh Hassan, Zahra Gafarzadeh, Constantin A Dasanu","doi":"10.1177/10781552241285591","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Employed in the treatment of malignancies and non-neoplastic conditions, hydroxyurea is associated with integumentary adverse effects, including skin discoloration, xerosis, pruritus, cutaneous atrophy, chronic leg ulcers, oral ulcerations, alopecia, and some nail abnormalities.</p><p><strong>Case report: </strong>A 77-year-old woman was diagnosed with essential thrombocytosis and started on low dose hydroxyurea. After 20 weeks of treatment, she experienced an unexpected change in hair color from gray to dark brown, without using hair dye or supplements. She later developed bilateral dorsal hand melanoderma, melanonychia, and onychodystrophy.</p><p><strong>Management and outcome: </strong>It was decided to monitor the patient with no action taken as she was happy with this side effect of hydroxyurea. The platelet count has remained in excellent control. The dark brown hair color persisted over time.</p><p><strong>Discussion/conclusion: </strong>Hair hyperpigmentation likely occurred through melanocyte activation via hydroxyurea. Severe side effects may require dosage adjustments, while milder effects can be monitored closely. The newly observed hair color restoration in this case highlights potential dual (therapeutic and aesthetic) applications of this class of agents.</p>","PeriodicalId":16637,"journal":{"name":"Journal of Oncology Pharmacy Practice","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oncology Pharmacy Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10781552241285591","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Employed in the treatment of malignancies and non-neoplastic conditions, hydroxyurea is associated with integumentary adverse effects, including skin discoloration, xerosis, pruritus, cutaneous atrophy, chronic leg ulcers, oral ulcerations, alopecia, and some nail abnormalities.

Case report: A 77-year-old woman was diagnosed with essential thrombocytosis and started on low dose hydroxyurea. After 20 weeks of treatment, she experienced an unexpected change in hair color from gray to dark brown, without using hair dye or supplements. She later developed bilateral dorsal hand melanoderma, melanonychia, and onychodystrophy.

Management and outcome: It was decided to monitor the patient with no action taken as she was happy with this side effect of hydroxyurea. The platelet count has remained in excellent control. The dark brown hair color persisted over time.

Discussion/conclusion: Hair hyperpigmentation likely occurred through melanocyte activation via hydroxyurea. Severe side effects may require dosage adjustments, while milder effects can be monitored closely. The newly observed hair color restoration in this case highlights potential dual (therapeutic and aesthetic) applications of this class of agents.

一名因血小板增多症接受羟基脲治疗的老年患者的头发几乎完全重新着色。
简介:羟基脲被用于治疗恶性肿瘤和非肿瘤性疾病,但羟基脲也会对皮肤产生不良影响,包括皮肤变色、干枯、瘙痒、皮肤萎缩、慢性腿部溃疡、口腔溃疡、脱发和一些指甲异常:一名 77 岁的妇女被诊断为原发性血小板增多症,并开始服用小剂量羟基脲。治疗 20 周后,在没有使用染发剂或补充剂的情况下,她的头发颜色意外地从灰色变为深棕色。后来,她患上了双侧手背黑皮病、黑斑病和趾骨营养不良症:由于患者对羟基脲的副作用感到满意,因此决定对其进行监测,不采取任何措施。血小板计数一直得到很好的控制。随着时间的推移,深棕色的发色仍在持续:头发色素沉着可能是由于羟基脲激活了黑色素细胞。严重的副作用可能需要调整剂量,而较轻的副作用可以密切监测。在本病例中新观察到的头发颜色恢复突显了这类药物潜在的双重(治疗和美容)应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.70
自引率
7.70%
发文量
276
期刊介绍: Journal of Oncology Pharmacy Practice is a peer-reviewed scholarly journal dedicated to educating health professionals about providing pharmaceutical care to patients with cancer. It is the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP). Publishing pertinent case reports and consensus guidelines...
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信